David Vancraeynest
Overview
Explore the profile of David Vancraeynest including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahnama N, Colson A, Baldin P, Pasquet A, Gruson D, Vancraeynest D, et al.
JACC Adv
. 2025 Feb;
4(3):101592.
PMID: 39933366
Background: Advances in congenital heart disease (CHD) management have improved survival rates, resulting in a growing population of women of childbearing age with CHD. These women face higher risk of...
2.
Krug P, Geets X, Berliere M, Duhoux F, Beauloye C, Pasquet A, et al.
Eur J Radiol
. 2025 Jan;
183:111909.
PMID: 39798205
Background: Ancillary breast cancer (BC) radiation therapy (RT), particularly associated with chemotherapy, increases the risk of coronary artery disease (CAD). However, it remains unclear whether this risk also applies to...
3.
Kefer J, Vancraeynest D, Roelants V, Belkhir L
Eur Heart J Case Rep
. 2024 Aug;
8(8):ytae384.
PMID: 39132296
No abstract available.
4.
Altes A, Levy F, Hanet V, De Azevedo D, Krug P, Iacuzio L, et al.
JACC Adv
. 2024 Aug;
3(7):101023.
PMID: 39130021
Background: Women with severe primary mitral regurgitation (MR) have lower surgery rates than men and could suffer from delayed referral for mitral valve (MV) intervention, exposing them to an increased...
5.
Hamid N, Bursi F, Benfari G, Vanoverschelde J, Tribouilloy C, Biagini E, et al.
JACC Asia
. 2024 Aug;
4(6):468-480.
PMID: 39100700
Background: Clinical outcome and interventional thresholds for degenerative mitral regurgitation (DMR) were developed in studies of patients at European and American institutions (EAIs), but little is known about patients at...
6.
Lejeune S, Ginion A, Menghoum N, Vancraeynest D, Pasquet A, Gerber B, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(2):56.
PMID: 39077419
Background: Inflammation and oxidative stress are thought to play an important role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF) through the development of endothelial dysfunction. Myeloperoxidase...
7.
Vancraeynest D, Pouleur A, de Meester C, Pasquet A, Gerber B, Michelena H, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jul;
25(12):1703-1711.
PMID: 38996050
Aims: Operating on patients with severe degenerative mitral regurgitation (DMR) is based on ACC/AHA or ESC/EACTS guidelines. Doubts persist on best surgical indications and their potential association with postoperative survival...
8.
De Azevedo D, Boute M, Tribouilloy C, Marechaux S, Pouleur A, Bohbot Y, et al.
JACC Adv
. 2024 Jun;
3(3):100830.
PMID: 38938822
Background: International guidelines recommend aortic valve replacement (AVR) as Class I triggers in high-gradient severe aortic stenosis (HGSAS) patients with symptoms and/or left ventricular ejection fraction (LVEF) <50%. The association...
9.
De Azevedo D, Tribouilloy C, Marechaux S, Pouleur A, Bohbot Y, Rusinaru D, et al.
JACC Adv
. 2024 Jun;
2(2):100254.
PMID: 38938309
Background: Up to 30% of patients with severe aortic stenosis (SAS) (indexed aortic valve area [AVAi] <0.6 cm/m) exhibit low-transvalvular gradient despite normal ejection fraction. There is intense debate regarding...
10.
Avierinos J, Tribouilloy C, Bursi F, Grigioni F, Vanoverschelde J, Resseguier N, et al.
Eur Heart J
. 2024 May;
45(26):2306-2316.
PMID: 38751052
Background And Aims: Presentation, outcome, and management of females with degenerative mitral regurgitation (DMR) are undefined. We analysed sex-specific baseline clinical and echocardiographic characteristics at referral for DMR due to...